IRIS
GALATI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.986
NA - Nord America 934
EU - Europa 436
SA - Sud America 80
AF - Africa 26
OC - Oceania 6
Totale 5.468
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 3.356
US - Stati Uniti d'America 900
CN - Cina 341
IT - Italia 182
HK - Hong Kong 149
GB - Regno Unito 67
FR - Francia 55
BR - Brasile 51
DE - Germania 37
VN - Vietnam 37
IN - India 25
FI - Finlandia 19
NL - Olanda 17
CZ - Repubblica Ceca 15
MX - Messico 15
CA - Canada 12
PL - Polonia 11
TR - Turchia 11
AR - Argentina 9
BD - Bangladesh 9
ZA - Sudafrica 8
ES - Italia 7
PE - Perù 7
SA - Arabia Saudita 7
CL - Cile 6
IQ - Iraq 6
MY - Malesia 6
AU - Australia 5
PK - Pakistan 5
SE - Svezia 5
UA - Ucraina 5
EG - Egitto 4
ID - Indonesia 4
KE - Kenya 4
RU - Federazione Russa 4
AE - Emirati Arabi Uniti 3
JP - Giappone 3
NP - Nepal 3
PH - Filippine 3
TH - Thailandia 3
AO - Angola 2
AZ - Azerbaigian 2
BH - Bahrain 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
LB - Libano 2
LT - Lituania 2
MA - Marocco 2
UY - Uruguay 2
VE - Venezuela 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BF - Burkina Faso 1
BO - Bolivia 1
BW - Botswana 1
CH - Svizzera 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
EC - Ecuador 1
GN - Guinea 1
HT - Haiti 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
IS - Islanda 1
JO - Giordania 1
KH - Cambogia 1
KI - Kiribati 1
KR - Corea 1
KZ - Kazakistan 1
MU - Mauritius 1
NI - Nicaragua 1
OM - Oman 1
PY - Paraguay 1
RO - Romania 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 5.468
Salva come PNG Salva come JPEG
Città #
San Jose 295
Singapore 256
Ashburn 188
Rome 147
Hong Kong 146
Beijing 116
Hefei 103
Dallas 71
Boardman 55
London 50
Lauterbourg 42
Shanghai 36
Munich 25
Santa Clara 22
Council Bluffs 19
Los Angeles 17
Brno 15
Seattle 15
Ho Chi Minh City 14
San Francisco 13
São Paulo 13
Mexico City 12
New York 11
Turku 11
Amsterdam 10
Warsaw 10
West Jordan 10
Boston 9
Helsinki 8
Washington 7
Orem 6
Pune 6
Toronto 6
Guangzhou 5
Hanoi 5
Johannesburg 5
Manchester 5
Paris 5
Sona 5
Brooklyn 4
Chennai 4
Lima 4
Montreal 4
Nairobi 4
Stockholm 4
Chicago 3
Frankfurt am Main 3
Haiphong 3
Krasnodar 3
Kuala Lumpur 3
Lahore 3
Riyadh 3
Secaucus 3
Uberlândia 3
Bangkok 2
Basra 2
Boydton 2
Buffalo 2
Cairo 2
Camden 2
Canberra 2
Caracas 2
Central 2
Dnipro 2
Genoa 2
Goiânia 2
Hengshui 2
Jeddah 2
Kirkuk 2
Manama 2
Manaus 2
Melbourne 2
Naples 2
New Delhi 2
Philadelphia 2
Poplar 2
Suffern 2
Taizhou 2
Tangshan 2
Tokyo 2
Wuxi 2
Zhengzhou 2
Adana 1
Ahmedabad 1
Almere Stad 1
Alvorada 1
Amman 1
Ankara 1
Antipolo City 1
Anápolis 1
Arad 1
Asahikawa 1
Atlanta 1
Augusta 1
Bacolod City 1
Baghdad 1
Baguio City 1
Bahadurgarh 1
Baku 1
Belém 1
Totale 1.919
Salva come PNG Salva come JPEG
Nome #
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 243
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation 239
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 225
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 224
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 223
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 222
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 220
Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 217
Distortion-product otoacoustic emissions: a useful test for monitoring ototoxicity induced by pegylated interferon and ribavirin treatment in patients with chronic hepatitis C 213
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 212
The hepatic expression of lysosomal acid lipase (LAL) is reduced in NAFLD patients, and associated with features of genetically determined LAL deficiency and NAFLD activity score 204
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 203
Assessment of liver function by the exhaled breath-print during chronic liver disease 200
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 191
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 155
Diabetes in chronic liver disease: from old concepts to new evidence 130
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 129
A challenging alfa-fetoprotein in a cirrhotic patient 126
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 117
Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography 115
Acoustic Radiation Forced Impulse of the Liver and the Spleen, Combined with Spleen Dimension and Platelet Count in New Ratio Scores, Identifies High-Risk Esophageal Varices in Well-Compensated Cirrhotic Patients 113
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 108
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 107
Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis 100
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 76
The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients 57
Hepatic toll-like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD 56
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease 53
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 52
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 51
Telaprevir raises the plasma/whole blood ribavirin ratio: trying to come full circle on a dangerous relationship 50
Non‐invasive assessment of hepatic steatosis by ultrasound‐derived fat fraction in individuals at high‐risk for metabolic dysfunction‐associated steatotic liver disease 49
Hepatic complications of bariatric surgery : the reverse side of the coin 49
Subcellular shift of the hepatic growth hormone receptor with progression of hepatitis C virus-related chronic liver disease 49
Lack of reduction of serum alphafetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with HCV-related cirrhosis 49
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 48
Lower schooling, higher hepatitis C virus prevalence in Italy: an association dependent on age 47
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens 46
Hepatocellular carcinoma in alcoholic liver disease: current management and recent advances 46
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis 44
Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis 44
GAS EXCHANGE AND PULMONARY MICROCIRCULATION ABNORMALITIES IN CIRRHOTIC AND NON-CIRRHOTIC CHRONIC LIVER DISEASE PATIENTS FREE FROM HEPATOPULMONARY SYNDROME 43
Surgical complications after resection of adrenal carcinoma 41
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 40
Haemorrhoidal disease in severe portal hypertension: a combined approach with transjugular intrahepatic portosystemic shunt (TIPS) and transanal haemorrhoidal dearterialization (THD) 40
Hepatitis C and double-hit B cell lymphoma successfully treated by antiviral therapy 39
Non-cirrhotic portal hypertension with large regenerative nodules: a diagnostic challenge 38
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 38
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 35
Peripheral graft infection due to Staphylococcus aureus without abnormal findings by 99mTc-HMPAO-labeled-leukocyte scan 35
Platelet count may impact on lysosomal acid lipase activity determination in dried blood spot 34
Totale 5.485
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.154
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.154
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202283 0 0 4 0 0 2 0 0 5 0 0 72
2022/202333 6 0 1 1 0 2 9 4 0 1 9 0
2023/2024194 8 13 6 20 13 79 2 13 3 12 7 18
2024/20253.571 35 17 55 9 55 66 51 7 111 183 1.481 1.501
2025/20261.604 169 81 112 145 83 110 513 116 139 136 0 0
Totale 5.485